secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2024-11-27T23:59:59+00:00
Accession:  0001493152-24-047999
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech adopts Cash Conservation Plan; independent directors paid entirely in stock
--------------------------------------------------------------------------------

- Independent directors will receive 100% of board compensation in shares, effective immediately; no cash compensation.
- Twice-monthly stock grants valued at closing price on last trading day before grant.
- Previously announced CEO Thomas Equels and COO Peter Rodino agreed to reduce cash salaries by $200k and $50k, effective Sept 11, 2024.
- Company encourages shareholders to vote for incumbent directors at Dec 17, 2024 annual meeting on WHITE proxy card.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315224047999/0001493152-24-047999-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315224047999/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-047999

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer